Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study
Authors
Keywords
KRAS mutation, Codon 12, Codon 13, BRAF mutation, Colorectal cancer, Sex, Prognosis
Journal
Biology of Sex Differences
Volume 4, Issue 1, Pages 17
Publisher
Springer Nature
Online
2013-09-11
DOI
10.1186/2042-6410-4-17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
- (2013) A I Phipps et al. BRITISH JOURNAL OF CANCER
- Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer
- (2013) Sakarias Wangefjord et al. Diagnostic Pathology
- BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer
- (2013) David Capper et al. INTERNATIONAL JOURNAL OF CANCER
- A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
- (2012) J Eberhard et al. BRITISH JOURNAL OF CANCER
- Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
- (2012) Björn Nodin et al. Diagnostic Pathology
- BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis
- (2012) Matthew F. Kalady et al. DISEASES OF THE COLON & RECTUM
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers
- (2012) Catherine E. Bond et al. PLoS One
- Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study
- (2012) Jenny Brändstedt et al. Biology of Sex Differences
- Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study
- (2012) Marie Fridberg et al. Biology of Sex Differences
- Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
- (2011) A Larsson et al. BRITISH JOURNAL OF CANCER
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Tumor TP53 expression status, body mass index and prognosis in colorectal cancer
- (2011) Teppei Morikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Association of CTNNB1 (β-Catenin) Alterations, Body Mass Index, and Physical Activity With Survival in Patients With Colorectal Cancer
- (2011) Teppei Morikawa JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
- (2011) Sakarias Wangefjord et al. Biology of Sex Differences
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
- (2010) Inti Zlobec et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer
- (2009) Garrett M. Nash et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
- (2009) J Souglakos et al. BRITISH JOURNAL OF CANCER
- A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Short term outcome after emergency and elective surgery for colon cancer
- (2008) O. H. Sjo et al. Colorectal Disease
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now